IL-IFT
9.5.2023 14:01:28 CEST | Business Wire | Press release
The Institute of Food Technologists (IFT), a nonprofit scientific organization committed to advancing the science of food and its application across the global food system, and the Seeding The Future Foundation are proud to announce the return of the annual Seeding The Future Global Food System Challenge. The Challenges invites scientists, engineers, innovators, entrepreneurs, and multidisciplinary teams from non-governmental organizations (NGOs), non-profits, social enterprises, universities, research institutions as well as small and emerging startups to submit their game-changing innovations that will help transform the global food system.
Now in its third year, the Challenge will once again award $1 million in grants and prizes via Seed Grants ($25,000 each), Growth Grants ($100,000 each), and Seeding The Future Grand Prizes ($250,000 each). Last year’s Growth Grant and Grand Prize winners included:
- Commercializing black soldier fly larvae as chicken feed to enhance egg nutrition and lower the cost of eggs in Rwanda. (Food Systems for the Future)
- Eliminating dangerous aflatoxins from smallholder supply chains starting with peanuts in Haiti. (Acceso)
- Accelerating the deployment of aquaponics that combine soilless crop production and fish farming to increase global food production in the face of climate change. (INMED Partnerships for Children)
- Community-led solar powered cold storage program to enable access to improved agricultural techniques and practices in rural developments. (Smart Villages Resource Group)
- Leveraging the US Postal Service to bring fresh produce from farms to front doors. (World Wildlife Fund)
“The Global Food System Challenge is meant to be a call to action to the global food community. More than 840 million people suffer from chronic hunger, severe undernutrition, and extreme poverty while more than 30% of food is wasted globally every year. Climate change, conflicts and poverty prevent equitable access to safe and nutritious food for many populations in both developed and developing regions. We urgently need impactful and transformative innovations that will lead to a sustainable food system and enable access of healthy, affordable, and appealing food that consumers trust,” said Bernhard van Lengerich, founder of Seeding The Future Foundation.
While application submissions open on June 1 and close on August 1, interested participants can review guidelines here to begin preparing their submission.
Since 2021, more than 1,500 submissions from 75 countries have been received from multidisciplinary teams from academic and research institutions, non-profits, and startups. The Challenge is funded by the Seeding The Future Foundation and hosted by IFT.
“The Seeding The Future Global Food System Challenge mirrors IFT’s mission and commitment to addressing food insecurity and ensuring a healthy future for our global food supply,” said IFT CEO Christie Tarantino-Dean. “We are thrilled to be partnering once again with Bernhard and the Seeding The Future Foundation on one of the most important showcases of food innovation and ingenuity.”
For more information, visit ift.org/food-system-challenge. Applicants needing additional support are encouraged to review Frequently Asked Questions.
About Institute of Food Technologists
The Institute of Food Technologists (IFT) is a global organization of approximately 12,000 individual members from more than 100 countries committed to advancing the science of food. Since 1939, IFT has brought together the brightest minds in food science, technology and related professions from academia, government, and industry to solve the world’s greatest food challenges. IFT works to ensure that its members have the resources they need to learn, grow and advance the science of food as the population and the world evolve. IFT believes that science is essential to ensuring a global food supply that is sustainable, safe, nutritious, and accessible to all. For more information, please visit ift.org.
About Seeding The Future Foundation
The Seeding The Future Foundation is a private, non-profit organization motivated by its core value that everyone should always have equitable access to safe, nutritious, affordable, appealing, and trusted food. It seeks to inspire innovative solutions that can help transform the global food system to be more sustainable and benefit the health of people and the environment. The Foundation provides seed funding and support to promising ideas and high impact innovations to improve food systems globally, technologies to reduce post-harvest losses in developing regions, as well as foundational work in academia and research. For more information, please visit seedingthefuture.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230509005101/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom